Physician profile
Robert P Runner
NPI 1134563661
$10,350.13
in general payments reported to CMS, 2019-2025
18 companies · $968 in 2025
The $968 reported for 2025 was less than what a typical Adult Reconstructive Orthopaedic Surgery provider received nationally (typical 2025 total: $1,425).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,634 · 2021: $570 · 2022: $1,508 · 2023: $831 · 2024: $3,839 · 2025: $968.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,848 · Travel and Lodging: $1,656 · Consulting Fee: $134.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,848.33 |
| Travel and Lodging | $1,656.11 |
| Consulting Fee | $134.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $2,991.82 | 2021-2025 | Mako, Accolade, X3 |
| Zimmer Biomet Holdings, INC. | $1,529.68 | 2022-2025 | Persona, Mymobility Platform, Arcos |
| Medical Device Business Services, INC. | $1,132.55 | 2019 | |
| Depuy Synthes Sales INC. | $1,033.16 | 2021-2025 | Attune, Na, Lcp |
| Encore Medical, Lp | $939.69 | 2019 | |
| Corin USA | $510.59 | 2019 | |
| Smith+Nephew, INC. | $435.64 | 2019-2023 | Real Intelligence, Journey II, Pico 7 |
| Next Science LLC | $374.21 | 2024-2025 | Xperience, Blastx, Surgx |
| Sanara Medtech INC. | $308.98 | 2022-2024 | Celleraterx |
| Orthalign INC | $210.57 | 2024-2025 | Orthalign Plus |
| Total Joint Orthopedics, INC. | $199.78 | 2024 | |
| Medtronic, INC. | $193.63 | 2021-2024 | Intellis Adaptivestim |
| Uoc USA INC | $167.27 | 2022-2025 | Uts, Conformity, U-Mii, U2 Revision Stem, Psa, Ustar, U2 Knee |
| Avanos Medical | $159.46 | 2021 | |
| Bioventus LLC | $80.76 | 2023 | Durolane |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pylant Medical | $35.29 | 2025 | |
| Innovation Technologies INC | $25.00 | 2025 | Irrisept |
| Pacira Pharmaceuticals Incorporated | $22.05 | 2025 | Zilretta |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Runner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.